Navigation Links
Essilor : First Half 2009 Results
Date:8/26/2009

r.com/reports#interim

    ------------------------
    Next financial announcement:
    Third-quarter revenue will be announced on Thursday, October 22, 2009.
    -----------------------

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(r), Crizal(r), Essilor(r) and Definity(r) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 293 lens finishing laboratories and local distribution networks.

The Essilor share trades on the NYSE Euronext Paris market and is included in the CAC 40 index.

    Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg:
EI:FP.
    ------------------------

                                MANAGEMENT REPORT

                                 First-Half 2009


    EUR millions               First-half 2009 First-half 2008 % Change

    Revenue                        1,663.4         1,520.2        +9.4%
    Contribution from                302.6           276.3        +9.5%
    operations(1)
                                      18.2%           18.2%
    % of revenue
    Operating profit                 281.9           261.7        +7.7%
    Profit attributable to           202.4           198.3        +2.1%
    equity holders of Essilor
    International

    % of revenue                      12.2%           13.0%
    Basic earnings per share          0.98            0.96        +2.4%
    (in EUR)

(1) Operating profit before compensation costs of share-based payments, restructuring costs, other income and expense, and goodwill impairment.

Revenue up 9.4% to EUR1,663.4 million

Essilor's consolidated revenue for the six months ended June 30, 2009 rose by 5.3%, excluding the currency effect, and by 0.7% like-for-like. Changes in the scope of consolid
'/>"/>

SOURCE Essilor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
2. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
3. Essilor Enters Bulgarian Market
4. Essilor : 2007 Results
5. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
6. Essilors 2008 First-Quarter Report
7. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
8. Essilor - First-Half 2008 Revenue
9. Essilor Steps Up its Development in Eastern Europe
10. Essilor Agrees to Acquire Signet Armorlite
11. Essilor : 2008 Revenue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... After suffering from women,s hair loss...rowing back and she,s sharing her progress and the... women through the release of her video diaries wh... and during her treatment. , ...r loss sufferer Zsanett Siklosi has released the ...
(Date:11/23/2009)...O,Pa.,Nov.23/PRNewswire-FirstCall/--InfoLogix,Inc....risemobilitysolutionsforthehealthcareandcommercial...identofManagedServicesatSiemensHealthServices,hasj...Services. ,, (Logo: http://www.newscom.com/cgi-...entofStrategicHealthcareServicesforInfoLogix,Mr.Wa...
(Date:11/23/2009)...rs of cancer patients and survivors treated with c...t often become chronic conditions, hindering patie...ists at the University of Rochester Medical Center...xperienced sleep troubles at nearly three times th...more prevalent in younger patients and those with ...
(Date:11/23/2009)...w their odds drop by 63 percent with moderate-to-h...23 (HealthDay News) -- Moderate-to-high intensity ...elp reduce stroke risk in older men but not in wom...most 3,300 men and women, average age 69, in Manha...g that time, there were 238 strokes among the part...
(Date:11/23/2009)...p weaknesses of drug approval process in United St...3 (HealthDay News) -- Problems with the popular ar...eart attack, stroke and death, were known for year...market in 2004, a new report says. , Contrary ...ngerous side effects were evident in 2000, a year ...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4
...with cervical spinal injury may have more damage t...hed in the Annals of Emergency Medicine, say that ...n patients over and above the normal X-rays.// ...re than a third of patients who were thought to ha...
..., researchers from University of South Florida had...Gerontology: Psychological Sciences that the more ... may have a role to play in reducing the risk of d... and dementia in general. Researchers had discover...
Dengue, the mosquito-transmitted lethal disease that has claimed 15 lives and afflicted 1,000 people in West Bengal so far, has been declared an epidemic by the state government.// State Health Di
...tment of had discovered a new way to test the stem...// The researchers had used a non-invasive i... trace stem cells’ destinations after being inject... myocardial infarctions in seven dogs, six of whic...
...l significantly reduces the spread of gastrointest...ilies studied, half of the families, which used th... in the spread of illness related to the gastroint...zer and educational materials on hand hygiene. The...
...ve that governs the flow of blood into a large blo...o various organs of the body. // It prevents the b...est of the body. The effective functioning of.... The defect can be present right form birth or it...
Other Medicine News:Health News:Alcohol based sanitizer found to reduce illness in families 2Health News:Percutaneous aortic valve replacement- a revolution in Cardiac Surgery 2
(Date:11/23/2009)...,Nov.23/PRNewswire-USNewswire/--JubilantOrganosys,...nResearchInstitutetodayannouncedajointventurethatw...ablingtechnologiesintheareasofOncology,MetabolicDi...bitragedandleveragedpartnershipthatwillacceleratet...wide.AMemorandumofUnderstandingwassignedtodayinWas...
(Date:11/23/2009)...-BioTrendsResearchGroup,Inc.releasedWave2ofits La...lti-phasesyndicatedmarketresearchprojecttrackingth...efirstsixmonthsofproductavailability.Eachwaveofthe...ephrologistsandqualitativeinformationfromasubsetof...touse,reasonstouse,typicalpatienttypes,productperc...
(Date:11/23/2009)...rstCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:C...any( http://www.cordblood-america.com )focusedonbr...linsurancepolicy,tofamiliesnationwideandinternatio...withCEOandco-founderMatthewSchisslerisnowavailable...e/2875811 . ,, Intheinterview,Mr.Schisslerupdat...
Breaking Medicine Technology:Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 1Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 2Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 3Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 1Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 2PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 1PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 2PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 3PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 4PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 5PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 6
...to Timeline for Second Pivotal Phase 3 Trial CL-05... Advanced Life,Sciences Holdings, Inc. , today ann...ata from Trial CL-06, the first of two,pivotal Pha... and,effectiveness of cethromycin, a novel once-a-...uired pneumonia (CAP). The Company,also provided a...
..., July 2, 2007-Women with at least three sites of,...times more likely,than average women to develop br...c Cancer Center led study of women with atypical,h... 1 issue of the,Journal of Clinical Oncology., Sev...erplasia,(also called atypia) in breast tissue is ...
Other Medicine Technology:Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 2Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 3
Carter Sphere Introducer and Holder
Symblepharon Ring - Medium
Oval Sponge Implants - 3.0 x 5.0 x 100 mm
Grooved Segmental Buckle - 2.3 x 6.4 x 80 mm
Medicine Products: